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Expression of the US28 transgene in VS28 mice. (A) Diagram of the 
VS28 transgene. Expression of US28 is driven by the 9-kb mouse villin 
promoter (mVillin). (B) US28 mRNA expression in jejunum, ileum, and 
colon of WT, VS28L18, VS28L19, and VS28L36 mice. Values were stan-
dardized to ubiquitin. Results represent the mean ± SEM (n = 3–4). 
(C) Radioligand competition assay using [125I]-CCL5 on membranes 
of IECs isolated from of the small intestine (SI) or large intestine (LI) of 
WT or VS28L18 mice. Results are expressed as specific binding (SB) in 
disintegrations per minute (DPM) divided by total protein. Results rep-
resent the mean ± SEM (n = 3). *P < 0.05, ***P < 0.001 vs. WT. (D–G) 
Representative images of the jejunum (D and E) and colon (F and G) 
of WT (D and F) and VS28L19 (E and G) mice stained with US28 (red) 
and DAPI (blue). Scale bar: 50 μm (D and E); 25 μm (F and G).
Figure 2
Histological changes in VS28 mice. (A and B) H&E staining of the 
jejunum of WT (A) and VS28L19 mice (B). Scale bar: 100 μm. (C–E) 
Decreased villus length (C) and increased crypt size (D) in VS28L19 
mice compared with those of WT mice. (E) Correspondingly, the villus/
crypt ratio is decreased in VS28L19 mice compared with that of WT. On 
average, 80 crypts were measured for each mouse. Results represent 
the mean ± SEM (n = 12 mice per group). ***P < 0.001 vs. WT.
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US28 expression induces IEC proliferation. (A and B) FACS analy-
sis showing a relative (A) and absolute (B) increase of BrdU-positive 
CD45– IECs from the jejunum of VS28L19 mice compared with those 
of WT littermates. Numbers indicate the percentage of BrdU+ cells. 
Results represent the mean ± SEM (n = 3 mice per group). **P < 0.01 
vs. WT mice. (C and D) Increased Ki67-positive cells in VS28L19 mice 
(D) compared with those in WT mice (C). The inset shows a high mag-
nification of intestinal crypts and reveals expression of US28 in Ki67+ 
cells. Staining of the jejunum with DAPI (blue), US28 (red), and Ki67 
(green). Scale bar: 100 μm (C and D); 25 μm (D, inset).
Figure 4
Expression of US28 in IECs leads to activation of Wnt and MAPK 
pathways. (A) Increased mRNA levels of the Wnt target genes 
c‑myc, Birc5, and Ccnd1 in IECs from VS28L19 mice. Notice that 
the mRNA levels of Ctnnb1 were not changed. The dashed line 
indicates WT values. Values were standardized to ubiquitin Results 
represent the mean ± SEM (n = 3–4 mice per group). **P < 0.01, 
***P < 0.001 vs. WT. (B) Western blot analysis of total β-catenin, 
phosphorylated GSK-3β/Ser9, active non-phosphorylated β-catenin 
(αABC), cyclin-D1, survivin, and phosphorylated Erk1/2 in IECs from 
VS28L19 and WT mice. A representative blot is show of from 3 inde-
pendent experiments (n = 4).
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Prevalence of neoplasms in VS28 mice
Mice	 Age	(wk)	 Adenocarcinoma	 Adenoma	 Multiplicity
WT 40–65 (0/50) 0% (0/50) 0% N/A
VS28L18 39–64 (1/49) 2% (3/49) 6% 1.3 ± 0.3
VS28L19 40–68 (1/25) 4% (9/25) 36%A,B 2.2 ± 0.5
VS28L36 40–43 (0/12) 0% (3/12) 25%C 2.0 ± 0.6
Mice (39–68 weeks of age) were examined for the presence of intestinal 
neoplasia. AP < 0.001 vs. WT. BP < 0.01 vs. VS28L18. CP < 0.01 vs. WT. 
N/A, not applicable.
Figure 5
US28 is expressed in Lgr5+ intestinal stem cells. (A) GFPhi and GFPneg 
IECs were sorted from LGR5 and LGR5S28 mice. Numbers indi-
cate the percentage of GFPhi IECs. (B and C) GFP (B) and US28 
(C) mRNA expression in sorted cells from the small intestine of LGR5 
and LGR5S28 mice. Values were standardized to ubiquitin. Results 
represent the mean ± SEM (n = 3). (D and E) US28 is expressed in 
Lgr5+ (GFP) cells. Staining of the jejunum of LGR5S28 mice with DAPI 
(blue), US28 (red), and GFP (green). The inset shows colocalization of 
US28 in Lgr5+ cells in white. Scale bar: 25 μm (D and E).
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Colonic and jejunal tumors in VS28 mice. (A and B) H&E-stained sections of a poorly differentiated colon carcinoma found in a VS28L18 mouse 
at 42 weeks of age. (C) H&E-stained section of jejunal tubular adenoma with high-grade dysplasia found in a VS28L19 mouse. (D and E) Tumors 
found in VS28 mice are positive for pan-keratin, Ki67 (D), and US28 (E). Representative sections stained with DAPI (blue), pan-keratin (D, 
green), Ki67 (D, red), or US28 (E, red) are shown. (F) β-catenin is present in the nucleus (white) of an adenoma (right side of the dashed line) 
of a VS28L19 mouse. No nuclear translocation is seen in normal crypts (left side of the dashed line). Representative sections stained with DAPI 
(red) and β-catenin (green) are shown. Nuclear translocation (double staining) is indicated in white. (G) Jejunal adenomas express cyclin-D1. A 
representative section stained with DAPI (blue) and cyclin-D1 (red) is shown. (H) Survivin was found in the cytosol of jejunal tubular adenomas 
(right side of the dashed line), in contrast to its normal nuclear localization (left side of the dashed line). Scale bar: 200 μm (A); 100 μm (B–D); 
50 μm (E and G); 20 μm (F and H).
Figure 7
Response of VS28 and WT mice to AOM/DSS. (A) Schematic of AOM/
DSS administration. Mice were injected with 12 mg/kg AOM and sub-
jected to three 7-day cycles of 2.5% DSS. (B and C) Representative 
H&E-stained sections of adenomas found after AOM/DSS treatment in 
WT (B) and VS28L18 mice (C). Scale bar: 50 μm. (D and E) The number 
of polyps (E) and the polyp area (D) were significantly increased in the 
VS28L18 mice (n = 11) compared with those of the WT littermates (n = 11). 
Results represent the mean ± SEM. *P < 0.05, ***P < 0.001 vs. WT.
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Transgenic coexpression of the inflammatory chemokine CCL2 exac-
erbates the phenotype of VS28L18 mice. The inflammatory chemokine 
CCL2 is an agonist for US28. To test whether CCL2 can activate 
US28 in vivo, we generated mice expressing both CCL2 and US28 
in IECs. (A) Generation of mice expressing both CCL2 and US28 in 
IECs (V2S28 mice). A 9-kb fragment of the villin promoter was used 
to drive expression of mouse CCL2 (mCCL2) to IECs (VCCL2 mice). 
Subsequently, the VCCL2 transgenic mice were crossed with VS28L18 
mice to generate V2S28 mice. (B) CCL2 and US28 mRNA expression 
in the jejunum of WT, VCCL2, VS28L18, and V2S28 mice. Values were 
standardized to ubiquitin (n = 3). (C–E) H&E staining of the jejunum of 
VS28L18 (C), VCCL2 (D), and V2S28 mice (E). (F) Analysis of BrdU+ 
incorporation in CD45– IECs from the jejunum of WT, VCCL2, VS28L18, 
and V2S28 mice was determined using FACS analysis (n = 4 mice 
per group). *P < 0.05, ***P < 0.001 vs. WT. #P < 0.05, ##P < 0.01 vs. 
VS28L18. (G) H&E-stained section of jejunal tubular adenoma found in 
a V2S28 mouse. Scale bar: 100 μm (C–E and G). Results represent 
the mean ± SEM.
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Prevalence of neoplasms in V2S28 mice
Mice	 Age	(wk)	 Adenoma	 Multiplicity
WT 38–45 (0/36) 0% N/A
VS28L18 38–43 (0/7) 0% N/A
V2S28 38–44 (2/10) 20%A 1
V2S28 mice were examined for the presence of intestinal neoplasia and 
compared with littermates. AP < 0.05 vs. WT.
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CAAAT-3′,  5′-AGCTGAACTAGTCGTGGAATAGCA-3′),  c-Myc  (Myc, 
5′-CGGCGGTGGCAACTTC-3′, 5′-CCTCCAAGTAACTCGGTCATCAT-3′), 
Survivin (Birc5, 5′-GCGGAGGCTGGCTTCA-3′, 5′-AAAAAACACTGGGC-
CAAATCA-3′),  Cyclin-D1  (Ccnd1,  5′-TCCGCAAGCATGCACAGA-3′, 





























































































US28  is  transcribed  in  latently  infected  THP-1 
monocytes. J Virol. 2001;75(13):5949–5957.
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